Cutaneous melanoma mortality starting to change: A study of trends in Northern Ireland

European Journal of Cancer

Volumn 45, Issue 13, 2009, Pages 2360-2366

  Montella, Anthony ^a   Gavin, Anna ^b   Middleton, Richard ^b   Autier, Philippe ^a   Boniol, Mathieu ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Cutaneous melanoma; Incidence; Mortality; Trends

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; POPULATION RESEARCH; PRIORITY JOURNAL; SEX DIFFERENCE; UNITED KINGDOM;

ADULT; AGED; FEMALE; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; NORTHERN IRELAND; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 68549100791     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.03.004     Document Type: Article

References (31)

1. Parkin DM, Whelan SL, Ferlay J, Storm H. Cancer incidence in five continents, vol. I-VIII. IARC CancerBase No. 7. Lyon.
2. Curado MP, Edwards B, Shin HR, et al., editors. Cancer incidence in five continents, vol. IX. IARC Scientific Publications No 160. Lyon: IARC; 2007.
3. Marrett L.D., Nguyen H.L., and Armstrong B.K. Trends in the incidence of cutaneous malignant melanoma in New South Wales 1983-1996. Int J Cancer 92 3 (2001) 457-462
4. Lipsker D.M., Hedelin G., Heid E., Grosshans E.M., and Cribier B.J. Striking increase of thin melanomas contrasts with stable incidence of thick melanomas. Arch Dermatol 135 12 (1999) 1451-1456
5. Balzi D., Carli P., Giannotti B., Paci E., and Buiatti E. Cutaneous melanoma in the Florentine area, Italy: incidence, survival and mortality. Eur J Cancer Prev 12 1 (2003) 43-48
6. Stang A., Stang K., Stegmaier C., Hakulinen T., and Jöckel K.H. Skin melanoma in Saarland: incidence, survival and mortality 1970-1996. Eur J Cancer Prev 10 5 (2001) 407-415
7. Downing A., Newton-Bishop J.A., and Forman D. Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in relation to stage of disease, 1993-2003. Brit J Cancer 95 1 (2006) 91-95
8. MacKie R.M., Bray C.A., Hole D.J., et al. Scottish Melanoma Group Incidence of and survival from malignant melanoma in Scotland: an epidemiological study. Lancet 360 9333 (2002) 587-591
9. Garbe C., McLeod G.R., and Buettner P.G. Time trends of cutaneous melanoma in Queensland. Aust Central Eur Cancer 89 6 (2000) 1269-1278
10. Rigel D.S., Friedman R.J., Kopf A.W., and Polsky D. ABCDE - an evolving concept in the early detection of melanoma. Arch Dermatol 141 8 (2005) 1032-1034
11. Boniol M., Sallin J., and Dore J.F. Time trends of cutaneous melanoma in Queensland. Aust Central Eur Cancer 94 6 (2002) 1902-1903
12. Hoey S.H.E., Devereux C.E.J., Murray L., et al. Skin cancer trends in Northern Ireland and consequences for provision of dermatology services. Brit J Dermatol 156 6 (2007) 1301-1307
13. McMullen E.A., Kee F., Patterson C.C., Gavin A.T., and Dolan O.M. Improved survival for melanoma in Northern Ireland: a comparison of two 5-year periods (1984-88 and 1994-98). Brit J Dermatol 151 3 (2004) 587-593
14. Segi M. Cancer mortality for selected sites in 24 countries (1950-57). Sendai: Tohoku University School of Public Health; 1960.
15. Joinpoint Regression Program. Version 3.2 - January 2008. Statistical Research and Applications Branch, National Cancer Institute.
16. Kim H.J., Fay M.P., Feuer E.J., and Midthune D.N. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19 (2000) 335-351 [correction 2001;20:655]
17. Klein LR. A textbook of Econometrics; 1953. p. 258.
18. Burton C., Coates M.S., Hersey P., et al. An analysis of a melanoma epidemic. Int J Cancer 55 5 (1993) 765-770
19. MacLennan R., Green A.C., McLeod G.R., and Martin N.G. Increasing incidence of cutaneous melanoma in Queensland. Aust J Natl Cancer Inst 84 18 (1992) 1427-1432
20. MacKie R.M., Hole D., Hunter J.A., et al. Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94 The Scottish Melanoma Group. BMJ 315 7116 (1997) 1117-1121
21. Thörn M., Bergström R., Adami H.O., and Ringborg U. Trends in the incidence of malignant melanoma in Sweden, by anatomic site, 1960-1984. Am J Epidemiol 132 6 (1990) 1066-1077
22. Newnham A., and Møller H. Trends in the incidence of cutaneous malignant melanomas in the south east of England, 1960-1998. J Public Health Med 24 4 (2002) 268-275
23. Bulliard J.L., and Cox B. Cutaneous malignant melanoma in New Zealand: trends by anatomical site, 1969-1993. Int J Epidemiol 29 3 (2000) 416-423
24. Lee J.A.H. The systematic relationship between melanomas diagnosed in situ and when invasive. Melanoma Res 11 5 (2001) 523-529
25. Thörn M., Pontén F., Johansson A.M., and Bergström R. Rapid increase in diagnosis of cutaneous melanoma in situ in Sweden, 1968-1992. Cancer Detect Prev 22 5 (1998) 430-437
26. Owen T., Fitzpatrick D., Dolan O., and Gavin A. Knowledge, attitudes and behaviour in the sun: the barriers to behavioural change in Northern Ireland. Ulster Med J 73 2 (2004) 96-104
27. Stratigos A., Nikolaou V., Kedicoglou S., et al. Melanoma/skin cancer screening in a Mediterranean country: results of the Euromelanoma Screening Day Campaign in Greece. J Eur Acad Dermatol Venereol 21 1 (2007) 56-62
28. Karim-Kos H.E., de Vries E., Soerjomataram I., Lemmens V., Siesling S., and Coebergh J.W. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 44 10 (2008) 1345-1389
29. Goretti H. Changing women's lives in Ireland. Int Socialism J (2001) 91
30. Whiteman D.C., Watt P., Purdie D.M., Hughes M.C., Hayward N.K., and Green A.C. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst 95 11 (2003) 806-812
31. del Marmol V., de Vries E., Roseeuw D., et al. A Prime minister managed to attract elderly men in a Belgian Euromelanoma campaign. Eur J Cancer 45 9 (2009) 1532-1534